ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

China flag China · Delayed Price · Currency is CNY
42.61
-0.14 (-0.33%)
Mar 9, 2026, 4:00 PM EDT
113.05%
Market Cap 6.45B
Revenue (ttm) 374.46M
Net Income (ttm) -51.72M
Shares Out 151.47M
EPS (ttm) -0.34
PE Ratio n/a
Forward PE n/a
Dividend 0.20 (0.47%)
Ex-Dividend Date Jul 10, 2025
Volume 1,939,780
Average Volume 3,975,379
Open 42.01
Previous Close 42.75
Day's Range 41.31 - 42.63
52-Week Range 18.00 - 61.11
Beta 0.22
RSI 63.30
Earnings Date Apr 28, 2026

About ChengDa Pharmaceuticals

ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally. It offers process research and development, process optimization, quality and stability research, customized production and other services for pharmaceutical intermediates and APIs; and food and feed additives, such as L-carnitine and L-carnitine tartrate. The company also provides bulk drug products, including urogenital, nervous system, ... [Read more]

Sector Healthcare
Founded 1980
Employees 656
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301201
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.